Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
The deals are part of Eli Lilly's effort to expand into infectious disease research and development.
Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals basliginda one cikan gelisme: The deals are part of Eli Lilly's effort to expand into infectious disease research and development.
Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.